Nadeem Kizilbash
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Blood groups and transfusion 2
- Genetics 3
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Jaweria Ambreen (5 shared papers)Khuram Shahzad (2 shared papers)Hassan M. Khachfe (3 shared papers)Nida Suhail (3 shared papers)Muhammad Ajmal (2 shared papers)Haseeb Anwar (1 shared paper)Muhammad Siddiq (3 shared papers)Sajid Malik (5 shared papers)
- Journals
- RSC Advances (1 paper)Archives of Medical Science (1 paper)Current Pharmaceutical Biotechnology (1 paper)Molecules (1 paper)Heliyon (1 paper)
- Partner nations
- Saudi ArabiaPakistanUnited States
In The Last Decade
Nadeem Kizilbash
31 papers receiving 319 citations
Peers
Comparison fields: 5 of 89
- Pharmaceutical Science 35
- Hematology 37
- Complementary and alternative medicine 26
- Molecular Medicine 10
- Pharmacology 16
Countries citing papers authored by Nadeem Kizilbash
This map shows the geographic impact of Nadeem Kizilbash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadeem Kizilbash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadeem Kizilbash more than expected).
Fields of papers citing papers by Nadeem Kizilbash
This network shows the impact of papers produced by Nadeem Kizilbash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadeem Kizilbash. The network helps show where Nadeem Kizilbash may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadeem Kizilbash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2023 | 36 | |
| 3 | 2023 | 29 | |
| 4 | 2014 | 27 | |
| 5 | 2013 | 27 | |
| 6 | 2003 | 21 | |
| 7 | 2022 | 20 | |
| 8 | 2016 | 17 | |
| 9 | Design of a Microemulsion-Based Drug Delivery System for Diclofenac Sodium | 2011 | 14 |
| 10 | 2023 | 11 | |
| 11 | 2013 | 8 | |
| 12 | 2015 | 7 | |
| 13 | 2016 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2013 | 5 | |
| 16 | 2015 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2025 | 3 |
About Nadeem Kizilbash
Nadeem Kizilbash is a scholar working on Hematology, Genetics, Immunology, Organic Chemistry and Molecular Medicine, having authored 31 papers that have together received 326 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (3 papers), Neonatal Health and Biochemistry (3 papers), Blood groups and transfusion (2 papers), Hydrogels: synthesis, properties, applications (2 papers), Surfactants and Colloidal Systems (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Porphyrin and Phthalocyanine Chemistry (2 papers) and Folate and B Vitamins Research (2 papers). The work is most often cited by research in Pharmaceutical Science (35 citations), Hematology (37 citations), Complementary and alternative medicine (26 citations), Molecular Medicine (10 citations) and Pharmacology (16 citations). Nadeem Kizilbash has collaborated with scholars based in Saudi Arabia, Pakistan and United States. Frequent co-authors include Jaweria Ambreen, Khuram Shahzad, Hassan M. Khachfe, Nida Suhail, Muhammad Ajmal, Haseeb Anwar, Muhammad Siddiq, Sajid Malik, Asifa Ahmed and Hina Naeem. Their work appears in journals such as RSC Advances, Archives of Medical Science, Current Pharmaceutical Biotechnology, Molecules and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.